Evaluation of atomoxetine for first-line treatment of newly diagnosed, treatment-naïve children and adolescents with attention deficit/hyperactivity disorder

By Montoya Alonso   Hervas Amaia   Cardo Esther   Artigas Josep   Mardomingo María J.   Alda José A.   Gastaminza Xavier   García-Polavieja María J.   Gilaberte Inmaculada   Escobar Rodrigo  

Current Medical Research and Opinion, Vol. 25, Iss. 11, 2009-11 ,pp. : 2745-2754

Informa Healthcare

Access to resources Recommend Favorite

Passiflora incarnata in the treatment of attention-deficit hyperactivity disorder in children and adolescents

By Akhondzadeh Shahin   Mohammadi MR   Momeni F  

Therapy, Vol. 2, Iss. 4, 2005-07 ,pp. : 609-614

Future Medicine

Access to resources Recommend Favorite

Attention deficit hyperactivity disorder (ADHD) in children and adolescents

By  

PROGRESS IN NEUROLOGY AND PSYCHIATRY, Vol. 19, Iss. 3, 2015-05 ,pp. : 16-23

John Wiley & Sons Inc

Access to resources Recommend Favorite

A multi-centre, randomised, open-label study of atomoxetine compared with standard current therapy in UK children and adolescents with attention-deficit/hyperactivity disorder (ADHD)

By Prasad Suyash   Harpin Val   Poole Lynne   Zeitlin Harry   Jamdar Saroj   Puvanendran Kanagasabai    

Current Medical Research and Opinion, Vol. 23, Iss. 2, 2007-02 ,pp. : 379-394

Informa Healthcare

Access to resources Recommend Favorite

Treatment stabilization in children and adolescents with attention-deficit/hyperactivity disorder: data from the Netherlands

By Sasané Rahul   Hodgkins Paul   Meijer Willemijn  

Current Medical Research and Opinion, Vol. 26, Iss. 11, 2010-11 ,pp. : 2565-2574

Informa Healthcare

Access to resources Recommend Favorite